Business Wire

U.S. Voter Behavior Dominated by Relief and Disgust – Study by NayaDaya

23.9.2020 15:00:00 EEST | Business Wire | Press release

Share

Study on the presidential election, conducted by NayaDaya, YouGov, and Statista, shows that U.S. citizens will vote to prevent the undesirable from happening.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200923005036/en/

The study reveals emotions and behavior of U.S. citizens, evoked by the election of Trump and Pence or Biden and Harris. The most chosen emotions are relief, disgust, fear, and disappointment – distribution varies between candidates.

“For U.S. voters the election is mostly about avoiding an undesirable result, not about being emotionally uplifted by the candidates,” says Marcello Mortillaro, Ph.D and Senior Scientist, Partner of NayaDaya Inc.

The most chosen emotion for Trump’s re-election is disengaging disgust that indicates violating voters’ moral standards. Pence is Trump’s reflection: His re-election evokes even more disgust but overall less emotions. In Biden’s case, the most common emotion is relief, implying avoidance of a threat.

Mortillaro explains: “As for Biden, almost half of Democrats feel relief, a positive emotion with a low engaging impact. Harris is unlike Biden. She arouses positive, engaging emotions of pride, admiration and joy.” Among Republicans, disgust and fear are the strongest emotions toward both Harris’ and Biden’s elections.

The NayaDaya® Emotional and Behavioral Intelligence, which is based on scientific research independently conducted by the University of Geneva, Switzerland, was used to analyze the U.S. voter emotions.

Voter emotions predict voter behavior and engagement – percentages for loyals:

  • Trump 32%
  • Pence 27%
  • Biden 45%
  • Harris 42%

Among the young (18-34), 47% are loyal to Biden, 27% to Trump. Among the African-Americans, 58% are loyal to Biden, only 13% to Trump. More than a quarter of respondents are not in favor of Democrats or Republicans; 31% of them are positively engaged in Trump, 37% in Biden.

“In the context of significant phenomena like presidential elections, emotions are our key to understanding different perspectives and their behavioral consequences. Through data, insight, empathy, and impact we empower responsible leaders, media, brands, and organizations to thrive and shape the world,” says NayaDaya’s CEO Timo Järvinen.

Study facts:

  • YouGov online panel Sept 2-4, 2020
  • Sample represents U.S. adult population
  • N=1265, margin of error ±2.5 percentage points

Annex: Key findings

Full report and data: www.nayadaya.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Contacts – NayaDaya Inc.
Timo Järvinen, CEO
timo@nayadaya.com
+358 40 505 7745

Timo Salomäki, Head of Global Growth
timos@nayadaya.com
+358 40 709 2399

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Stitch Raises $25M Series A Led by Andreessen Horowitz14.5.2026 10:00:00 EEST | Press release

Stitch, the operating system built for modern financial institutions, today announced it has raised $25 million in Series A funding led by Andreessen Horowitz (a16z). The investment marks a16z’s first in the GCC and brings Stitch’s total funding to $35 million. In addition to a16z, existing investors Arbor Ventures, COTU Ventures, Raed Ventures, and SVC also participated in the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514070694/en/ Mohamed Oueida - Founder & CEO, Stitch (Photo: AETOSWire) Despite spending over $1 trillion on digital transformation in the last three years, most financial institutions are still running on the same fragmented, legacy infrastructure that has defined the sector for decades. Globally, banks spend $700 billion a year on technology — yet launching a new product still takes years, and upgrading a core system still risks bringing operations to a halt. Now, as AI reshapes every industry

Corona Global Named Most Valuable Beer Brand in Kantar BrandZ Rankings for Third Consecutive Year14.5.2026 07:01:00 EEST | Press release

Corona global has been recognized as the most valuable beer brand in the world for the third consecutive year in Kantar's BrandZ 2026 Most Valuable Global Brands report, released today. Eight out of the top ten most valuable global beer brands belong to AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD), according to the report ranking the best brands in the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513211378/en/ In 2025, Corona led AB InBev’s performance, increasing revenue by 8.3% outside of its home market with double-digit volume growth in 30 markets, while Corona Cero delivered strong double-digit volume growth. As the brand celebrated its 100th anniversary, Corona launched its global “Corona 100” platform, including a multi-year sponsorship of a renowned concert at Copacabana Beach in Rio de Janeiro. Strong momentum continued in Q1 2026, with AB InBev delivering all-time high revenues and volume growt

The Bolivarian Republic of Venezuela Announces the Initiation of a Comprehensive Public Debt Restructuring Process13.5.2026 23:08:00 EEST | Press release

The Bolivarian Republic of Venezuela announces today its decision to initiate a comprehensive restructuring of its external public debt obligations. CONTEXT & RATIONALE Over the past decade, Venezuela's economy has been severely impacted by external shocks – from the end of the commodity super-cycle to foreign sanctions and COVID-19 – resulting in a sharp economic contraction, a protracted default since 2017, and a ballooning of public sector liabilities. The country nonetheless possesses a strong economic potential, including unique hydrocarbon and mineral endowments. A recovery is underway, and Venezuela is committed to accelerating it through a comprehensive reform agenda in support of growth, fiscal sustainability, monetary stabilization, and enhanced governance. Restoring public debt sustainability is central to this agenda: the current debt overhang constrains external financing, limits public investment capacity, and prevents full re-engagement with the international financial s

Boomi Announces Intent to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across the Enterprise13.5.2026 22:00:00 EEST | Press release

Boomi, the data activation company for AI, today announced it has signed a letter of intent to acquire Lunar.dev, an innovator in AI and MCP gateway. The proposed acquisition is expected to enrich the Boomi Enterprise Platform and Boomi Connect with advanced capabilities to govern and scale AI usage across enterprise systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513850557/en/ Boomi Announces Intent to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across the Enterprise As organizations move from AI experimentation to production, controlling how agents and AI applications interact with LLMs at scale has become critical. Lunar.dev addresses this need with an AI gateway that delivers granular, policy-driven control over AI interactions, with the visibility, security, and performance required for enterprise environments. These capabilities enable organizations to move from pilot to production with confiden

BeOne Medicines’ BEQALZI ™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma13.5.2026 20:27:00 EEST | Press release

BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to BEQALZI™(bee-KAHL-zee; sonrotoclax), a foundational, next-generation BCL2 inhibitor, for the treatment of adult patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL), after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase (BTK) inhibitor. BEQALZI was designed to enhance BCL2 inhibition—with greater potency, selectivity, and a pharmacologic profile with potential to improve efficacy, tolerability, and convenience over others in the class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513542161/en/ BeOne Medicines' flagship U.S. biologics manufacturing and clinical R&D facility at the Princeton West Innovation Campus in Hopewell, N.J. Michael Wang, M.D., Global Principal Investigator

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye